FDA Inspection 1158171 — Birth Tissue Recovery
The FDA completed an inspection of Birth Tissue Recovery on Oct 21, 2021 in Raleigh, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 21, 2021
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Raleigh, NC (United States)